General Archive
-
News releases
LifeArc and Cleveland Clinic join forces to develop new monoclonal antibody therapeutics for patients with high unmet medical needs
LifeArc and Cleveland Clinic, a nonprofit, multispecialty academic medical centre, have signed a new 10-year Master Services Agreement (MSA) for…
-
News releases
MRC Technology highlights presentation of data for antibody candidate lambrolizumab developed using its humanization technology
The humanized antibody is now being developed by MSD, known as Merck in the US and Canada. Lambrolizumab is an…